To view this page ensure that Adobe Flash Player version 11.1.0 or greater is installed.
The Cutting Edge RESEARCH & REGULATIONS TELEMONITORED CARDIAC DEVICES ARE FOR GOOD A recent study published in the Lancet affirms positive outcomes associated with remote monitoring of patients with implanted cardiac devices. At the end of the trial, 18.9% of telemonitored patients’ condition had worsened, compared to 27.2% of control group patients. In addition, ten telemonitored patients versus 27 control group patients died during follow-up. These results highlight the potential for beneficial clinical outcomes of remote monitoring implanted cardiac devices. Courtesy of Biotronik During the yearlong trial, medical data from telemonitoring-enabled cardiac devices were sent to a modified mobile phone, then relayed to a service center, where health data is repackaged into a report for physicians to view on a secure website. Any heart rhythm disturbances were transmitted via fax, SMS or email. OW YOUNG ONCOLOGISTS USE SMARTPHONE AT WORK Published in the Journal of Radiation Oncology, a survey conducted among 131 young French radiation oncologist residents revealed that 78 percent of smartphone owners report using the phone at work. According to the study, the most common medical use for smartphones was to capture photos of patient lesions for diagnosis, follow-up, or second opinion, followed by utility apps falling into categories such as drug-referencing tools, manufacturer contact and even radiation dose calculations. H Authors cite concerns regarding the validity of apps and note that some apps are created for academic purposes only, and use in medical applications may breach End-User License Agreements. 13 MedicalExpo e-magazine